Dr. Ariel Moradzadeh, MD

Dr. Moradzadeh practices at South Pacific Surgery Center in Beverly Hills, California.

Dr. Moradzadeh's NPI, 1689107922, was assigned on April 4, 2017. Dr. Moradzadeh graduated from David Geffen School of Medicine at UCLA in 2015. Dr. Moradzadeh holds California license A148329.

Dr. Moradzadeh's primary practice is South Pacific Surgery Center, at 99 La Cienega Boulevard Suite 102, Beverly Hills, CA 90211. The practice phone is (310) 360-7368.

Dr. Moradzadeh's primary practice is South Pacific Surgery Center in Beverly Hills, California. Dr. Moradzadeh is also affiliated with Cedars-Sinai Medical Center. The medical group on file is Cedars-Sinai Medical Group. Dmand AI also links Dr. Moradzadeh to 1 more hospital, 1 group practice or clinic and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moradzadeh practices, 5 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Moradzadeh's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Moradzadeh is board certified in urology by the American Board of Urology. Dmand AI has Dr. Moradzadeh's licenses on file in 3 states: California, Oregon and New Mexico.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, pelvic prolapse and prostate inflammation or infection among the conditions Dr. Moradzadeh treats.

CMS data shows 1,097 Medicare services from Dr. Moradzadeh across 16 procedure codes in 2024, for 400 Medicare patients. Medicare paid $61,610 for them.

CMS counts 400 Medicare patients who saw Dr. Moradzadeh in 2024. The largest group is 65 to 74, with 192 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Moradzadeh's median patient age at 64, with 14% women.

In 2024, Dr. Moradzadeh wrote 1,813 Medicare Part D claims for 483 patients. 88% of them were for generic drugs. CMS names the drug for 1,657 of them, across 21 drugs with 11 or more claims each, at $238,969 in total drug cost. In 2023, CMS named 1,239 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Moradzadeh for performance year 2024, reported as part of a group. Dr. Moradzadeh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Moradzadeh as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Moradzadeh in 2021. Dr. Moradzadeh's most frequent co-authors are Karyn S. Eilber, MD, Jennifer T. Anger, MD and Andrew A. Chen, MD.

CMS Open Payments shows 152 general payments to Dr. Moradzadeh from 34 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 77% of the total. Boston Scientific Corporation paid the most, $3,060.

Dr. Moradzadeh graduated from David Geffen School of Medicine at UCLA in 2015.

Dr. Moradzadeh is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.